Biomarker Testing Services

A Global Strategic Business Report

MCP29593

RESEARCH DASHBOARD

OCT 2025

RELEASE DATE

7147

EXECUTIVE POOL

5850

PRICE

816

EXPERT INPUTS

22

COMPANIES

100

DATA TABLES

152

PAGES

2

EDITION

WHAT'S BEHIND OUR DATA?

140857226

DOMAIN TRANSCRIPTS

6080276

BRANDS TRACKED

1729341

FEATURED COMPANIES

22574

TOPICS COVERED

82719

MARKET SEGMENTS

91

KEY INDUSTRIES

1574

CURATION TEAM

4761909

DECISION MAKERS

EXECUTIVE ENGAGEMENTS BY TIER (55)

3

CXO

5

VICE PRESIDENT

10

DIRECTOR

25

MANAGER

12

MARKETING

REQUEST FULL-STACK INDEX Includes 350+ pages validated sources

QUESTIONNAIRE EXECUTIVES DATA ROOM

OUR EXPERT PANELS

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

INFLUENCER INVITEE

WHY PARTICIPATE?

Expertise to the Power of YOU!

Collaborative Insights - Expand your deep domain insights from participants at competitive companies worldwide while you share your own!
Global Acumen Alerts - Expand your intelligence on your areas of interest by enabling our “Email Alerts” feature drawing from other influencers’ project participation.
Enterprise-wide Project Discounts - Discounts start @ 10% and build up as more participants support our ongoing projects in your space.
Complimentary Copies - We highly recommend collaboration with your team to draw upon their geographical domain expertise. Our platform enables collaborative engagements with 10 peers. When you or any of your team members purchase the report, the entire team will receive complimentary copies with full stack access to our data and updates for one year.
Annual Digital Subscription to one of the business publications or $100 value gift card - No Purchase Required! The lead participant will receive the digital subscription

The Economist
MIT Technology Review
Harvard Business Review

Note - Offer is limited to one participant per company. Offer may be withdrawn at anytime without notice once our annual maximum participation of leading players is fulfilled. Offer by invitation only, to enterprise executives in from companies featured in the project ranked. If you’ve received our initation, you’re qualified! If not, you may check your eligibility by registering to join our Project Expert Panel. Typically you must be have a Marketing, Strategy, Product Management or Business Development, role as a CXO or VP or Director or Manager directly involved with the P&L of the products or services covered in the report. You must complete all modules in the Primary Research Data Simulator.

MARKETGLASS

BASIC

Annual Prepaid Subscription
Single-User
10,000 Data Room Credits/Month
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use MarketGlass^TM Data Templates For Your Own Enterprise Data to Build Bespoke Research Reports.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.

PREMIUM

Annual Prepaid Subscription
One Research Project With One Complimentary Update/Year
10-User License
10-User Peer-to-Peer Collaborative Features
200 Domain Expert Insights (With Name, Company, and Date)
50,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

ENTERPRISE

Annual Prepaid Subscription
Four Research Projects With One Complimentary Update/Year
25-User License
25-User Peer-to-Peer Collaborative Engagements
500 Domain Expert Insights (With Name, Company, and Date)
150,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

HIGHLIGHTS & REPORT INDEX

Global Biomarker Testing Services Market to Reach US$1.1 Billion by 2030

The global market for Biomarker Testing Services estimated at US$700.5 Million in the year 2024, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 8.1% over the analysis period 2024-2030. Biomarker Assay Development & Validation Service, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$762.6 Million by the end of the analysis period. Growth in the Flow Cytometry Service segment is estimated at 7.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$184.1 Million While China is Forecast to Grow at 7.9% CAGR

The Biomarker Testing Services market in the U.S. is estimated at US$184.1 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$178.7 Million by the year 2030 trailing a CAGR of 7.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.5% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR.

Global Biomarker Testing Services Market - Key Trends & Drivers Summarized

Why Is Biomarker Testing Gaining Importance in Modern Healthcare?

Biomarker testing has become a cornerstone of precision medicine, enabling early disease detection, treatment monitoring, and patient stratification for targeted therapies. With the rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and autoimmune conditions, the need for reliable biomarker testing services has surged. These services facilitate more accurate diagnosis and treatment selection, ensuring better patient outcomes and reduced healthcare costs. The increasing reliance on biomarker-based diagnostics is also evident in the rapid expansion of personalized medicine. Pharmaceutical companies are integrating biomarker testing into drug development processes to identify patient populations that would benefit most from specific therapies. Additionally, regulatory agencies are mandating biomarker testing for companion diagnostics, ensuring drug efficacy and safety before market approval. As a result, healthcare providers and diagnostic laboratories are increasingly outsourcing biomarker testing services to specialized laboratories with advanced analytical capabilities.

How Are Technological Innovations Enhancing Biomarker Testing Services?

Technological advancements in genomics, proteomics, and bioinformatics are revolutionizing biomarker testing services, making them more precise, cost-effective, and accessible. Next-generation sequencing (NGS) and polymerase chain reaction (PCR) techniques have improved the detection of genetic and molecular biomarkers, allowing for earlier disease identification and risk assessment. Additionally, the integration of artificial intelligence (AI) and machine learning in biomarker data analysis is optimizing test accuracy and accelerating result interpretation. The emergence of liquid biopsy techniques is another groundbreaking development in biomarker testing. These minimally invasive tests enable real-time monitoring of disease progression by analyzing circulating tumor DNA (ctDNA) and other biomarkers in blood samples. Furthermore, advancements in multiplex biomarker assays allow for simultaneous testing of multiple biomarkers, reducing time and costs associated with traditional single-marker tests. As healthcare moves toward data-driven decision-making, these innovations are making biomarker testing services an indispensable tool in modern diagnostics and drug development.

What Market Trends Are Driving the Growth of Biomarker Testing Services?

The growing demand for early disease detection and personalized treatment plans is one of the key trends propelling the biomarker testing services market. Healthcare providers and researchers are prioritizing precision diagnostics to tailor treatments to individual patient profiles, leading to increased adoption of biomarker testing across various medical specialties. Oncology remains the largest application area, with biomarker-driven therapies playing a crucial role in immunotherapy, targeted cancer treatments, and chemotherapy response assessment. Another significant trend shaping the market is the rise of decentralized testing models. The shift toward home-based and point-of-care biomarker testing is being fueled by advances in telemedicine and remote patient monitoring technologies. Companies are developing portable biomarker testing kits and wearable biosensors to facilitate real-time health tracking, reducing the need for frequent hospital visits. Moreover, regulatory support for biomarker-driven clinical trials and drug approvals is encouraging pharmaceutical firms to integrate biomarker testing into their development pipelines, further boosting market demand.

What Are the Key Growth Drivers for the Biomarker Testing Services Market?

The growth in the Biomarker Testing Services market is driven by several factors including the rising incidence of chronic diseases, increasing adoption of precision medicine, and rapid technological advancements in biomarker detection methods. The expansion of companion diagnostics, which require biomarker testing for drug approval and patient selection, is further fueling market growth. Additionally, the increasing investment in clinical research and biotechnology innovations is expanding the scope of biomarker testing applications. Pharmaceutical companies are leveraging biomarker testing services to streamline drug development, reduce clinical trial failures, and enhance regulatory compliance. The shift toward non-invasive diagnostic techniques, such as liquid biopsy and multiplex biomarker panels, is also accelerating market expansion. As healthcare systems worldwide focus on improving diagnostic accuracy and treatment efficacy, biomarker testing services are expected to experience sustained growth, transforming the future of disease management and precision medicine.

SCOPE OF STUDY

The report analyzes the Biomarker Testing Services market by the following Segments, and Geographic Regions/Countries:

Segments:

Service (Biomarker Assay Development & Validation Service, Flow Cytometry Service, Other Services); Type (Molecular Biomarkers, Cellular Biomarkers); End-Use (Pharmaceutical & Biotechnology Companies End-Use, Research Institutes End-Use, CROs End-Use).

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World..

SELECT PLAYERS

ACM Global Laboratories; BioAgilytix Labs, LLC; Biomedica Medizinprodukte GmbH; Charles River Laboratories, Inc.; Creative Biolabs; Discovery Life Sciences; Frontage Laboratories, Inc.; Intertek Group Plc; Laboratory Corporation of America Holdings; NorthEast BioLab; Novigenix SA; Pacific Biolabs; Randox Laboratories Ltd.; Raybiotech, Inc.; Svar Life Science AB;

AI INTEGRATIONS

We’re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy

How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind

Biomarker Testing Services – Global Key Competitors Percentage Market Share in 2025 (E)

Competitive Market Presence - Strong/Active/Niche/Trivial for 22 Players Worldwide in 2025 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Expansion of Precision Medicine and Targeted Therapies Throws the Spotlight on Biomarker Testing Services

Rising Clinical Demand for Companion Diagnostics Drives Hospital and Lab Adoption of Biomarker Assays

Surge in Liquid Biopsy-Based Testing Accelerates Use of Non-Invasive Biomarkers in Clinical Decision-Making

OEM Focus on Multi-Gene Panels and Comprehensive Genomic Profiling Spurs Testing Service Innovation

Increased Use of Immune Checkpoint and MSI Markers in Oncology Fuels Growth of Specialized Testing Panels

Regulatory Approvals for Lab-Developed Tests and IVD Companion Diagnostics Support Market Commercialization

Growing Integration of Molecular Pathology and Centralized Lab Services Enhances Biomarker Testing Capacity

Expansion of Testing in Neurology, Cardiology, and Infectious Diseases Broadens Clinical Application Landscape

Use of AI for Pathology Image-Based Biomarker Detection Strengthens Digital Testing Platforms

Rising Demand for Real-Time Monitoring Biomarkers in Chronic Disease Management Propels Market Uptake

Growth in Hospital-Acquired Infection Biomarker Testing Supports Rapid Triage and Antibiotic Stewardship

OEM Partnerships With Diagnostic Labs Enhance Sample Volume and Data Generation for Longitudinal Studies

Development of Point-of-Care and Decentralized Testing Devices Fuels Access to Biomarker Testing in Rural Areas

OEM Investment in Harmonized Sample-to-Insight Workflows Improves Testing Efficiency and Clinical Turnaround

Expansion of Next-Generation Sequencing and PCR Infrastructure Supports Multiplexed Biomarker Analysis

Integration With EHR Systems and AI-Based Reporting Engines Enhances Clinical Decision Support Capabilities

Global Rollout of Tumor-Agnostic Therapies Strengthens Role of Genotype-Based Biomarker Testing

Demand for Cost-Effective Panel-Based Tests Encourages Adoption in Community Hospitals and Labs

Focus on Test Reproducibility and CLIA/CAP Compliance Drives Quality Assurance in Biomarker Testing Services

Shift Toward Value-Based Healthcare Models Supports Reimbursement for Outcome-Linked Biomarker Tests

4. GLOBAL MARKET PERSPECTIVE

World Recent Past, Current & Future Analysis for Biomarker Assay Development & Validation Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Biomarker Assay Development & Validation Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Flow Cytometry Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Flow Cytometry Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Other Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Molecular Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Molecular Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Cellular Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Cellular Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Pharmaceutical & Biotechnology Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Pharmaceutical & Biotechnology Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for CROs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for CROs End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Biomarker Testing Services Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

World Recent Past, Current & Future Analysis for Biomarker Testing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Biomarker Testing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES

Biomarker Testing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)

USA Recent Past, Current & Future Analysis for Biomarker Testing Services by Service - Biomarker Assay Development & Validation Service, Flow Cytometry Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

USA 6-Year Perspective for Biomarker Testing Services by Service - Percentage Breakdown of Value Sales for Biomarker Assay Development & Validation Service, Flow Cytometry Service and Other Services for the Years 2025 & 2030

USA Recent Past, Current & Future Analysis for Biomarker Testing Services by Type - Molecular Biomarkers and Cellular Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

USA 6-Year Perspective for Biomarker Testing Services by Type - Percentage Breakdown of Value Sales for Molecular Biomarkers and Cellular Biomarkers for the Years 2025 & 2030

USA Recent Past, Current & Future Analysis for Biomarker Testing Services by End-Use - Pharmaceutical & Biotechnology Companies End-Use, Research Institutes End-Use and CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

USA 6-Year Perspective for Biomarker Testing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, Research Institutes End-Use and CROs End-Use for the Years 2025 & 2030

CANADA

Canada Recent Past, Current & Future Analysis for Biomarker Testing Services by Service - Biomarker Assay Development & Validation Service, Flow Cytometry Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Canada 6-Year Perspective for Biomarker Testing Services by Service - Percentage Breakdown of Value Sales for Biomarker Assay Development & Validation Service, Flow Cytometry Service and Other Services for the Years 2025 & 2030

Canada Recent Past, Current & Future Analysis for Biomarker Testing Services by Type - Molecular Biomarkers and Cellular Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Canada 6-Year Perspective for Biomarker Testing Services by Type - Percentage Breakdown of Value Sales for Molecular Biomarkers and Cellular Biomarkers for the Years 2025 & 2030

Canada Recent Past, Current & Future Analysis for Biomarker Testing Services by End-Use - Pharmaceutical & Biotechnology Companies End-Use, Research Institutes End-Use and CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Canada 6-Year Perspective for Biomarker Testing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, Research Institutes End-Use and CROs End-Use for the Years 2025 & 2030

JAPAN

Biomarker Testing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)

Japan Recent Past, Current & Future Analysis for Biomarker Testing Services by Service - Biomarker Assay Development & Validation Service, Flow Cytometry Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Japan 6-Year Perspective for Biomarker Testing Services by Service - Percentage Breakdown of Value Sales for Biomarker Assay Development & Validation Service, Flow Cytometry Service and Other Services for the Years 2025 & 2030

Japan Recent Past, Current & Future Analysis for Biomarker Testing Services by Type - Molecular Biomarkers and Cellular Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Japan 6-Year Perspective for Biomarker Testing Services by Type - Percentage Breakdown of Value Sales for Molecular Biomarkers and Cellular Biomarkers for the Years 2025 & 2030

Japan Recent Past, Current & Future Analysis for Biomarker Testing Services by End-Use - Pharmaceutical & Biotechnology Companies End-Use, Research Institutes End-Use and CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Japan 6-Year Perspective for Biomarker Testing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, Research Institutes End-Use and CROs End-Use for the Years 2025 & 2030

CHINA

Biomarker Testing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)

China Recent Past, Current & Future Analysis for Biomarker Testing Services by Service - Biomarker Assay Development & Validation Service, Flow Cytometry Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

China 6-Year Perspective for Biomarker Testing Services by Service - Percentage Breakdown of Value Sales for Biomarker Assay Development & Validation Service, Flow Cytometry Service and Other Services for the Years 2025 & 2030

China Recent Past, Current & Future Analysis for Biomarker Testing Services by Type - Molecular Biomarkers and Cellular Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

China 6-Year Perspective for Biomarker Testing Services by Type - Percentage Breakdown of Value Sales for Molecular Biomarkers and Cellular Biomarkers for the Years 2025 & 2030

China Recent Past, Current & Future Analysis for Biomarker Testing Services by End-Use - Pharmaceutical & Biotechnology Companies End-Use, Research Institutes End-Use and CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

China 6-Year Perspective for Biomarker Testing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, Research Institutes End-Use and CROs End-Use for the Years 2025 & 2030

EUROPE

Biomarker Testing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)

Europe Recent Past, Current & Future Analysis for Biomarker Testing Services by Service - Biomarker Assay Development & Validation Service, Flow Cytometry Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Europe 6-Year Perspective for Biomarker Testing Services by Service - Percentage Breakdown of Value Sales for Biomarker Assay Development & Validation Service, Flow Cytometry Service and Other Services for the Years 2025 & 2030

Europe Recent Past, Current & Future Analysis for Biomarker Testing Services by Type - Molecular Biomarkers and Cellular Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Europe 6-Year Perspective for Biomarker Testing Services by Type - Percentage Breakdown of Value Sales for Molecular Biomarkers and Cellular Biomarkers for the Years 2025 & 2030

Europe Recent Past, Current & Future Analysis for Biomarker Testing Services by End-Use - Pharmaceutical & Biotechnology Companies End-Use, Research Institutes End-Use and CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Europe 6-Year Perspective for Biomarker Testing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, Research Institutes End-Use and CROs End-Use for the Years 2025 & 2030

Europe Recent Past, Current & Future Analysis for Biomarker Testing Services by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

Europe 6-Year Perspective for Biomarker Testing Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030

FRANCE

Biomarker Testing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)

France Recent Past, Current & Future Analysis for Biomarker Testing Services by Service - Biomarker Assay Development & Validation Service, Flow Cytometry Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

France 6-Year Perspective for Biomarker Testing Services by Service - Percentage Breakdown of Value Sales for Biomarker Assay Development & Validation Service, Flow Cytometry Service and Other Services for the Years 2025 & 2030

France Recent Past, Current & Future Analysis for Biomarker Testing Services by Type - Molecular Biomarkers and Cellular Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

France 6-Year Perspective for Biomarker Testing Services by Type - Percentage Breakdown of Value Sales for Molecular Biomarkers and Cellular Biomarkers for the Years 2025 & 2030

France Recent Past, Current & Future Analysis for Biomarker Testing Services by End-Use - Pharmaceutical & Biotechnology Companies End-Use, Research Institutes End-Use and CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

France 6-Year Perspective for Biomarker Testing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, Research Institutes End-Use and CROs End-Use for the Years 2025 & 2030

GERMANY

Biomarker Testing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)

Germany Recent Past, Current & Future Analysis for Biomarker Testing Services by Service - Biomarker Assay Development & Validation Service, Flow Cytometry Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Germany 6-Year Perspective for Biomarker Testing Services by Service - Percentage Breakdown of Value Sales for Biomarker Assay Development & Validation Service, Flow Cytometry Service and Other Services for the Years 2025 & 2030

Germany Recent Past, Current & Future Analysis for Biomarker Testing Services by Type - Molecular Biomarkers and Cellular Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Germany 6-Year Perspective for Biomarker Testing Services by Type - Percentage Breakdown of Value Sales for Molecular Biomarkers and Cellular Biomarkers for the Years 2025 & 2030

Germany Recent Past, Current & Future Analysis for Biomarker Testing Services by End-Use - Pharmaceutical & Biotechnology Companies End-Use, Research Institutes End-Use and CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Germany 6-Year Perspective for Biomarker Testing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, Research Institutes End-Use and CROs End-Use for the Years 2025 & 2030

ITALY

Italy Recent Past, Current & Future Analysis for Biomarker Testing Services by Service - Biomarker Assay Development & Validation Service, Flow Cytometry Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Italy 6-Year Perspective for Biomarker Testing Services by Service - Percentage Breakdown of Value Sales for Biomarker Assay Development & Validation Service, Flow Cytometry Service and Other Services for the Years 2025 & 2030

Italy Recent Past, Current & Future Analysis for Biomarker Testing Services by Type - Molecular Biomarkers and Cellular Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Italy 6-Year Perspective for Biomarker Testing Services by Type - Percentage Breakdown of Value Sales for Molecular Biomarkers and Cellular Biomarkers for the Years 2025 & 2030

Italy Recent Past, Current & Future Analysis for Biomarker Testing Services by End-Use - Pharmaceutical & Biotechnology Companies End-Use, Research Institutes End-Use and CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Italy 6-Year Perspective for Biomarker Testing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, Research Institutes End-Use and CROs End-Use for the Years 2025 & 2030

UNITED KINGDOM

Biomarker Testing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)

UK Recent Past, Current & Future Analysis for Biomarker Testing Services by Service - Biomarker Assay Development & Validation Service, Flow Cytometry Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UK 6-Year Perspective for Biomarker Testing Services by Service - Percentage Breakdown of Value Sales for Biomarker Assay Development & Validation Service, Flow Cytometry Service and Other Services for the Years 2025 & 2030

UK Recent Past, Current & Future Analysis for Biomarker Testing Services by Type - Molecular Biomarkers and Cellular Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UK 6-Year Perspective for Biomarker Testing Services by Type - Percentage Breakdown of Value Sales for Molecular Biomarkers and Cellular Biomarkers for the Years 2025 & 2030

UK Recent Past, Current & Future Analysis for Biomarker Testing Services by End-Use - Pharmaceutical & Biotechnology Companies End-Use, Research Institutes End-Use and CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UK 6-Year Perspective for Biomarker Testing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, Research Institutes End-Use and CROs End-Use for the Years 2025 & 2030

REST OF EUROPE

Rest of Europe Recent Past, Current & Future Analysis for Biomarker Testing Services by Service - Biomarker Assay Development & Validation Service, Flow Cytometry Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Europe 6-Year Perspective for Biomarker Testing Services by Service - Percentage Breakdown of Value Sales for Biomarker Assay Development & Validation Service, Flow Cytometry Service and Other Services for the Years 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for Biomarker Testing Services by Type - Molecular Biomarkers and Cellular Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Europe 6-Year Perspective for Biomarker Testing Services by Type - Percentage Breakdown of Value Sales for Molecular Biomarkers and Cellular Biomarkers for the Years 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for Biomarker Testing Services by End-Use - Pharmaceutical & Biotechnology Companies End-Use, Research Institutes End-Use and CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Europe 6-Year Perspective for Biomarker Testing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, Research Institutes End-Use and CROs End-Use for the Years 2025 & 2030

ASIA-PACIFIC

Biomarker Testing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)

Asia-Pacific Recent Past, Current & Future Analysis for Biomarker Testing Services by Service - Biomarker Assay Development & Validation Service, Flow Cytometry Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Asia-Pacific 6-Year Perspective for Biomarker Testing Services by Service - Percentage Breakdown of Value Sales for Biomarker Assay Development & Validation Service, Flow Cytometry Service and Other Services for the Years 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Biomarker Testing Services by Type - Molecular Biomarkers and Cellular Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Asia-Pacific 6-Year Perspective for Biomarker Testing Services by Type - Percentage Breakdown of Value Sales for Molecular Biomarkers and Cellular Biomarkers for the Years 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Biomarker Testing Services by End-Use - Pharmaceutical & Biotechnology Companies End-Use, Research Institutes End-Use and CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Asia-Pacific 6-Year Perspective for Biomarker Testing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, Research Institutes End-Use and CROs End-Use for the Years 2025 & 2030

REST OF WORLD

Rest of World Recent Past, Current & Future Analysis for Biomarker Testing Services by Service - Biomarker Assay Development & Validation Service, Flow Cytometry Service and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of World 6-Year Perspective for Biomarker Testing Services by Service - Percentage Breakdown of Value Sales for Biomarker Assay Development & Validation Service, Flow Cytometry Service and Other Services for the Years 2025 & 2030

Rest of World Recent Past, Current & Future Analysis for Biomarker Testing Services by Type - Molecular Biomarkers and Cellular Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of World 6-Year Perspective for Biomarker Testing Services by Type - Percentage Breakdown of Value Sales for Molecular Biomarkers and Cellular Biomarkers for the Years 2025 & 2030

Rest of World Recent Past, Current & Future Analysis for Biomarker Testing Services by End-Use - Pharmaceutical & Biotechnology Companies End-Use, Research Institutes End-Use and CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of World 6-Year Perspective for Biomarker Testing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, Research Institutes End-Use and CROs End-Use for the Years 2025 & 2030

COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)	% VALIDATED RESEARCH *
ACM Global Laboratories	%
BioAgilytix Labs	%
BIOMEDICA Medizinprodukte GmbH	%
Charles River Laboratories International, Inc.	%
Clinical Laboratories Pty Limited	%
Creative Biolabs	%
Discovery Life Sciences	%
Frontage Laboratories, Inc.	%
Intertek Group Plc	%
Labcorp Holdings Inc.	%

* Login to Participate & View Data Stacks

* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlass^TM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.

View All Companies...

PARTICIPATE NOW!

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]

DIFFERENTIATORS

Integrity Trust Transparency

Our research offerings primarily draw upon unique perspectives of participating executives and their experiences in operating and strategy roles. These geo-focused insights enrich our projects .

What we are NOT - Our reports are not editorial exercises of remote analysts’ secondary source fed content that predominantly flood today’s off-the-shelf market report business. (A review of 262 publishers).

WHAT SETS US APART

FULL STACK DATA ACCESS

Primary Research Cluster Data
Influencer Engagement Stats
Evidence of Primary Research
List of Companies Engaged
Hundreds of Pages of Research
Peer Collaborative Interactions
Enterprise Data Exchanges
MarketGlassTM Platform Insider
Geographic Pricing Dynamics
Competitive Shares by Country
Brand Curation & Insights
Domain Expert Pool

Program Transparency: Clients have access to engagement stats of companies and executives. Clients may commission third-party audits of our influencer engagements at their expense.

Primary Research: We have a very successful incentive driven primary research program presenting a rich experience to participating executives. Featured company executives can sign up for a complimentary.

Collaborative Intelligence: Our platform presents a unique features for executives to collaborate with peers across geographies and participate on various product or regional perspectives for a collective unified insider project experience.

Global Brand Intelligence: We present competitive brand intelligence at the company level for players worldwide. Executives from brand owner companies participate to curate each brand for relevance and market presence.

Bespoke Updates: Our peer-to-peer online interactive platform enables client companies to build upon our project data stacks to build bespoke editions for internal sharing and use. Client company can build one complimentary update per year and unlimited updates for additional fee. Bespoke updates are fulfilled within a two-day turnaround.

Enterprise EcoConnect: Discretely bounce off queries to participant pool of executives. We can reach out to our participant pool based on specifics of geographic or domain acumen.

Renowned Support: We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Complimentary Updates: Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

No Fluff: We offer our clients the best CX with clean easy to read content. No verbose fluff. We offer clients full access to the entire stack of hundreds of pages of secondary research feeds used in our project via our online MarketGlass portal.

Scroll